Drug Shortage Report for EMERADE
Report ID | 192281 |
Drug Identification Number | 02458446 |
Brand name | EMERADE |
Common or Proper name | EMERADE |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | EPINEPHRINE |
Strength(s) | 0.3MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR |
Packaging size | n/a |
ATC code | C01CA |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-05-03 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-05-11 |
Company comments | Possible device failure |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2023-05-11 | French | Compare |
v1 | 2023-05-11 | English | Compare |
Showing 1 to 2 of 2